Skip to main content
Equibles

STIFEL FINANCIAL CORP

Position in EDIT — Editas Medicine, Inc.

CIK 720672 ST. LOUIS, MO
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$242,293
+$43,380 QoQ
Shares Held
74,782
-7.1% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 216 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $538,947,950 across 105 Biotechnology names. EDIT ranks #83 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BHVN
Biohaven Ltd.
 9,941,165 $147,924,534
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 162,151 $80,545,262
3 MANE
Veradermics, Inc
 294,117 $36,158,743
4 JAZZ
Jazz Pharmaceuticals plc
 139,491 $33,613,146
5 REGN
Regeneron Pharmaceuticals, Inc.
 46,378 $28,918,535
6 OMER
Omeros Corp
 1,836,925 $17,469,155
7 NTLA
Intellia Therapeutics, Inc.
 1,014,387 $17,163,427
8 IONS
Ionis Pharmaceuticals Inc
 202,983 $16,094,521

All Filings in EDIT

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $242,293 74,782
2026-03-31 $198,913 80,532
2025-12-31 $91,927 44,843
2025-09-30 $2,013,588 580,285
2025-06-30 $1,221,593 555,270
2025-03-31 $411,552 354,787
2024-12-31 $428,190 337,158
2024-09-30 $2,130,827 624,876
2024-06-30 $2,116,536 453,220
2024-03-31 $1,734,076 233,703
2023-12-31 $1,545,969 152,613
2023-09-30 $1,185,264 151,957
2023-06-30 $1,219,908 148,227
2023-03-31 $1,031,805 142,318
2022-12-31 $535,065 60,323
2022-09-30 $1,139,384 93,087
2022-06-30 $1,069,218 90,382
2022-03-31 $1,214,958 63,878
2021-12-31 $339,309 12,780
2021-09-30 $635,014 15,458
2021-06-30 $4,448,675 78,543
2021-03-31 $2,899,554 69,037
2020-12-31 $895,164 12,768